Week in Review: VC 2012 Predictions and MediaMath Crowned King of DSPs
In the latest VentureView report, the National Venture Capital Association and Dow Jones & Co. reported that 63 percent of VCs think their portfolio companies…
Posted by
In the latest VentureView report, the National Venture Capital Association and Dow Jones & Co. reported that 63 percent of VCs think their portfolio companies…
Posted by
The convergence between life sciences and technology cannot be ignored. That’s why at Safeguard Scientifics, we consolidated of our life sciences and technology deal teams.…
Posted by
This week, we announced details for our Investor Day 2011, scheduled for Tuesday, October, 4 at The Yale Club of New York City. It’s a great…
Posted by
More IPO buzz this week. On Wednesday, its first day of trading, Pandora shares were as high as $26. The excitement dwindled a bit on…
Posted by
Last night, I had the pleasure of attending the Greater Philadelphia Alliance for Capital and Technologies (PACT) 18th Annual Enterprise Awards. For nearly 60 years,…
Posted by
Last week, Safeguard Scientifics’ President and CEO Peter J. Boni sat down with Gregg Greenberg of TheStreet.com to discuss the emergence of IPO candidates from…
Posted by
On the heels of continued IPO activity, there has been a flurry of media coverage — both positive and negative — regarding the companies that…
Posted by
While there are a wealth of opportunities to deploy capital in a variety of life sciences companies, the evolution and potential long-term impact of regenerative…
Posted by